The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms

Cell Adhesion and Migration

Volumn 7, Issue 2, 2013, Pages 232-236

  Lu, Zhen ^a   Bast, Robert C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytoskeleton; Integrin; Migration suppression; RhoA GTPase; STAT3; Tumor suppressor gene ARHI

Indexed keywords

BETA1 INTEGRIN; INTERLEUKIN 6; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAT3 PROTEIN;

AUTOPHAGY; CANCER INHIBITION; CANCER LOCALIZATION; CELL MIGRATION; CELL MOTILITY; CYTOPLASM; FOCAL ADHESION; GENE EXPRESSION; HUMAN; NOTE; OVARY CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS FIBER; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

EID: 84878795911     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.23648     Document Type: Note

References (67)

1. Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y, et al. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res 2004; 10:6559-66; PMID:15475444; http://dx.doi.org/10.1158/1078- 0432.CCR-04-0698
2. Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK, et al. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene 2012; 31:68-79; PMID:21643014; http://dx.doi.org/10.1038/onc.2011.213
3. Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J, et al. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 2011; 4:76-86; PMID:21071579; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0167
4. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118:3917-29; PMID:19033662.
5. Xu F, Xia W, Luo RZ, Peng H, Zhao S, Dai J, et al. The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice. Cancer Res 2000; 60:4913-20; PMID:10987306.
6. Yu Y, Luo R, Lu Z, Wei Feng W, Badgwell D, Issa JP, et al. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol 2006; 407:455-68; PMID:16757345; http://dx.doi.org/10.1016/S0076-6879(05)07037-0
7. Bouaouina M, Goult BT, Huet-Calderwood C, Bate N, Brahme NN, Barsukov IL, et al. A conserved lipid-binding loop in the kindlin FERM F1 domain is required for kindlin-mediated αIIbß3 integrin coactivation. J Biol Chem 2012; 287:6979-90; PMID:22235127; http://dx.doi.org/10.1074/jbc.M111.330845
8. Qin J, Wu C. ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. Curr Opin Cell Biol 2012; 24:607-13; PMID:22763012; http://dx.doi.org/10.1016/j.ceb.2012.06.003
9. Stachurska A, Elbanowski J, Kowalczyńska HM. Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions. Cell Biol Int 2012; 36:883-92; PMID:22686483; http://dx.doi.org/10.1042/CBI20110522
10. Rosenberger G, Meien S, Kutsche K. Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome. Hum Mutat 2009; 30:352-62; PMID:19035362; http://dx.doi.org/10.1002/humu.20855
11. Pfarrer C, Hirsch P, Guillomot M, Leiser R. Interaction of integrin receptors with extracellular matrix is involved in trophoblast giant cell migration in bovine placentomes. Placenta 2003; 24:588-97 PMID:12828918; http://dx.doi.org/10.1016/S0143-4004(03)00059-6
12. Müller-Klingspor V, Hefler L, Obermair A, Kaider A, Breitenecker G, Leodolte S, et al. Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary. Anticancer Res 2001; 21(3C):2185-8; PMID:11501844.
13. Wang L, Pedroja BS, Meyers EE, Garcia AL, Twining SS, Bernstein AM. Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly. PLoS One 2012; 7:e33915; PMID:22470492; http://dx.doi.org/10.1371/journal.pone. 0033915
14. Bianchi-Smiraglia A, Paesante S, Bakin AV. Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 2012; In press; PMID:22824793; http://dx.doi.org/10.1038/onc.2012.320
15. Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22:146-57; PMID:22264731; http://dx.doi.org/10.1016/j.dev-cel.2011.11.002
16. Lawson C, Schlaepfer DD. Integrin adhesions: who's on first? What's on second? Connections between FAK and talin. Cell Adh Migr 2012; 6:302-6; PMID:22983197; http://dx.doi.org/10.4161/cam.20488
17. Reuning U. Integrin αvβ3 promotes vitronectin gene expression in human ovarian cancer cells by implicating rel transcription factors. J Cell Biochem 2011; 112:1909-19; PMID:21433063; http://dx.doi.org/10.1002/jcb.23111
18. Lössner D, Abou-Ajram C, Benge A, Reuning U. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells. Int J Biochem Cell Biol 2008; 40:2746-61; PMID:18577466; http://dx.doi.org/10.1016/j.biocel.2008.05.014
19. Strell C, Niggemann B, Voss MJ, Powe DG, Zanker KS, Entschladen F. Norepinephrine promotes the β1-integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROα release. Mol Cancer Res 2012; 10:197-207; PMID:22127496; http://dx.doi.org/10.1158/1541-7786. MCR-11-0130
20. Schmid MC, Avraamides CJ, Foubert P, Shaked Y, Kang SW, Kerbel RS, et al. Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth. Cancer Res 2011; 71:6965-75; PMID:21948958; http://dx.doi.org/10.1158/0008-5472.CAN-11-0588
21. Kenny HA, Leonhardt P, Ladanyi A, Yamada SD, Montag A, Im HK, et al. Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis. Clin Cancer Res 2011; 17:459-71; PMID:21149615; http://dx.doi.org/ 10.1158/1078-0432.CCR-10-2258
22. Spivey KA, Banyard J. A prognostic gene signature in advanced ovarian cancer reveals a microfibril-associated protein (MAGP2) as a promoter of tumor cell survival and angiogenesis. Cell Adh Migr 2010; 4:169-71; PMID:20400864; http://dx.doi.org/10.4161/cam.4.2.11716
23. Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, et al. Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5) beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 2010; 70:2624-33; PMID:20332224; http://dx.doi.org/10.1158/0008-5472.CAN-09-3415
24. Shepherd TG, Mujoomdar ML, Nachtigal MW. Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion. J Ovarian Res 2010; 3:5; PMID:20187934; http://dx.doi.org/10.1186/ 1757-2215-3-5
25. Slack-Davis JK, Atkins KA, Harrer C, Hershey ED, Conaway M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 2009; 69:1469-76; PMID:19208843; http://dx.doi.org/10.1158/0008-5472. CAN-08-2678
26. Chen YJ, Wei YY, Chen HT, Fong YC, Hsu CJ, Tsai CH, et al. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J Cell Physiol 2009; 221:98-108; PMID:19475568; http://dx.doi.org/10.1002/jcp.21835
27. Tan TW, Lai CH, Huang CY, Yang WH, Chen HT, Hsu HC, et al. CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J Cell Biochem 2009; 107:345-56; PMID:19301259; http://dx.doi.org/10.1002/jcb.22132
28. Baumann F, Leukel P, Doerfelt A, Beier CP, Dettmer K, Oefner PJ, et al. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 2009; 11:368-80; PMID:19033423; http://dx.doi.org/10.1215/15228517-2008-106
29. Mukherjee S, Ray D, Lekli I, Bak I, Tosaki A, Das DK. Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action. Can J Physiol Pharmacol 2010; 88:1017-25; PMID:21076489; http://dx.doi.org/10.1139/Y10-082
30. Engel MA, Neurath MF. Anticancer properties of the IL-12 family - focus on colorectal cancer. Curr Med Chem 2010; 17:3303-8; PMID:20712574; http://dx.doi.org/10.2174/092986710793176366
31. Kwon EM, Holt SK, Fu R, Kolb S, Williams G, Stanford JL, et al. Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiol 2012; 36:347-53; PMID:22542949; http://dx.doi.org/10.1016/j.canep.2012.04.002
32. Meinhold-Heerlein I, Bauerschlag D, Hilpert F, Dimitrov P, Sapinoso LM, Orlowska-Volk M, et al. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 2005; 24:1053-65; PMID:15558012; http://dx.doi.org/10.1038/sj.onc.1208298
33. Dijkgraaf EM, Welters MJ, Nortier JW, van der Burg SH, Kroep JR. Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer. Curr Pharm Des 2012; 18:3816-27; PMID:22591418; http://dx.doi.org/10.2174/138161212802002797
34. Colomiere M, Ward AC, Riley C, Trenerry MK, Cameron-Smith D, Findlay J, et al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer 2009; 100:134-44; PMID:19088723; http://dx.doi.org/10.1038/sj.bjc.6604794
35. Duan Z, Bradner JE, Greenberg E, Levine R, Foster R, Mahoney J, et al. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation. Clin Cancer Res 2006; 12:6844-52; PMID:17121906; http://dx.doi.org/10.1158/1078-0432.CCR-06-1330
36. Azare J, Leslie K, Al-Ahmadie H, Gerald W, Weinreb PH, Violette SM, et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol Cell Biol 2007; 27:4444-53; PMID:17438134; http://dx.doi.org/10.1128/MCB.02404-06
37. Huang C, Yang G, Jiang T, Huang K, Cao J, Qiu Z. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro. J Exp Clin Cancer Res 2010; 29:51; PMID:20482858; http://dx.doi.org/10.1186/1756-9966-29-51
38. Shain KH, Yarde DN, Meads MB, Huang M, Jove R, Hazlehurst LA, et al. Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation. Cancer Res 2009; 69:1009-15; PMID:19155309; http://dx.doi.org/10. 1158/0008-5472.CAN-08-2419
39. Li R, Li G, Deng L, Liu Q, Dai J, Shen J, et al. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol Rep 2010; 23:1553-9; PMID:20428809; http://dx.doi.org/10.3892/or-00000795
40. Zhang X, Yin P, Di D, Luo G, Zheng L, Wei J, et al. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line. Anticancer Res 2009; 29:4497-501; PMID:20032397.
41. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36(13 Spec No):1621-30; PMID:10959048; http://dx.doi.org/10.1016/S0959-8049(00)00156-8
42. Kesanakurti D, Chetty C, Dinh DH, Gujrati M, Rao JS. Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma. Oncogene 2013; 32:327-40; PMID:22349830; http://dx.doi.org/10.1038/onc.2012.52
43. Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J Carcinog 2007; 6:11; PMID:17567918; http://dx.doi.org/10.1186/1477-3163-6-11
44. Leroy-Dudal J, Demeilliers C, Gallet O, Pauthe E, Dutoit S, Agniel R, et al. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2. Int J Cancer 2005; 114:531-43; PMID:15609323; http://dx.doi.org/10.1002/ijc. 20778
45. Hamadi A, Deramaudt TB, Takeda K, Rondé P. Hyperphosphorylated FAK Delocalizes from Focal Adhesions to Membrane Ruffles. J Oncol 2010; 2010; PMID:20847951; http://dx.doi.org/10.1155/2010/932803
46. Hamamura K, Jiang C, Yokota H. ECM-dependent mRNA expression profiles and phosphorylation patterns of p130Cas, FAK, ERK and p38 MAPK of osteoblast-like cells. Cell Biol Int 2010; 34:1005-12; PMID:20507284; http://dx.doi.org/10.1042/ CBI20100069
47. Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, et al. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. J Pharmacol Exp Ther 2010; 334:489-99; PMID:20472666; http://dx.doi.org/10.1124/jpet.110.165654
48. Shi C, Lu J, Wu W, Ma F, Georges J, Huang H, et al. Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway. PLoS One 2011; 6:e21482; PMID:21720547; http://dx.doi.org/10.1371/journal.pone.0021482
49. Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007; 67:684-94; PMID:17234779; http://dx.doi.org/10.1158/0008-5472.CAN-06-3166
50. Routray C, Liu C, Yaqoob U, Billadeau DD, Bloch KD, Kaibuchi K, et al. Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes. Am J Physiol Cell Physiol 2011; 301:C66-74; PMID:21451103; http://dx.doi.org/10.1152/ajpcell.00038.2011
51. Miertzschke M, Stanley P, Bunney TD, Rodrigues-Lima F, Hogg N, Katan M. Characterization of interactions of adapter protein RAPL/Nore1B with RAP GTPases and their role in T cell migration. J Biol Chem 2007; 282:30629-42; PMID:17716979; http://dx.doi.org/10.1074/jbc.M704361200
52. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, et al. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 2002; 22:901-15; PMID:11784865; http://dx.doi.org/10.1128/MCB.22.3.901-915.2002
53. Kim JC, Crary B, Chang YC, Kwon-Chung KJ, Kim KJ. Cryptococcus neoformans activates RhoGTPase proteins followed by protein kinase C, focal adhesion kinase, and ezrin to promote traversal across the blood-brain barrier. J Biol Chem 2012; 287:36147-57; PMID:22898813; http://dx.doi.org/10.1074/jbc.M112. 389676
54. Boccafoschi F, Mosca C, Bosetti M, Cannas M. The role of mechanical stretching in the activation and localization of adhesion proteins and related intracellular molecules. J Cell Biochem 2011; 112:1403-9; PMID:21321993; http://dx.doi.org/10.1002/jcb.23056
55. Payne SL, Hendrix MJ, Kirschmann DA. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex. J Cell Biochem 2006; 98:827-37; PMID:16440329; http://dx.doi.org/10.1002/jcb.20792
56. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E. Ligand-independent activation of c-Met by fibronectin and α(5)β(1)- integrin regulates ovarian cancer invasion and metastasis. Oncogene 2011; 30:1566-76; PMID:21119598; http://dx.doi.org/10.1038/onc.2010.532
57. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81:53-62; PMID:7536630; http://dx.doi.org/10.1016/0092-8674(95)90370-4
58. Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schütz A, Kovacic B, et al. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 2007; 9:279-91; PMID:17460772; http://dx.doi.org/10.1593/ neo.06820
59. Camand E, Peglion F, Osmani N, Sanson M, Etienne-Manneville S. N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration. J Cell Sci 2012; 125:844-57; PMID:22275437; http://dx.doi.org/10.1242/jcs.087668
60. Chang MH, Lee K, Lee KY, Kim YS, Kim YK, Kang JH. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer. APMIS 2012; 120:28-38; PMID:22151306; http://dx.doi.org/10.1111/j.1600-0463. 2011.02788.x
61. O'Connor KL, Chen M, Towers LN. Integrin α6β4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation. Am J Physiol Cell Physiol 2012; 302:C605-14; PMID:22049212; http://dx.doi.org/10. 1152/ajp-cell.00095.2011
62. Lydolph MC, Morgan-Fisher M, Høye AM, Couchman JR, Wewer UM, Yoneda A. Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp Cell Res 2009; 315:3312-24; PMID:19796635; http://dx.doi.org/10.1016/j.yexcr.2009.09.022
63. Rousseau M, Gaugler MH, Rodallec A, Bonnaud S, Paris F, Corre I. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration. Biochem Biophys Res Commun 2011; 414:750-5; PMID:22001926; http://dx.doi.org/10.1016/j.bbrc.2011.09.150
64. Di Ciano-Oliveira C, Thirone AC, Szászi K, Kapus A. Osmotic stress and the cytoskeleton: the R(h)ole of Rho GTPases. Acta Physiol (Oxf) 2006; 187:257-72; PMID:16734763; http://dx.doi.org/10.1111/j.1748-1716.2006.01535.x
65. Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005; 96:379-86; PMID:16053508; http://dx.doi.org/10.1111/j.1349-7006.2005.00062.x
66. Sepp KJ, Auld VJ. RhoA and Rac1 GTPases mediate the dynamic rearrangement of actin in peripheral glia. Development 2003; 130:1825-35; PMID:12642488; http://dx.doi.org/10.1242/dev.00413
67. Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001; 12:2711-20; PMID:11553710.